Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does lipitor affect glucosamine's impact on joint health?How does lipitor's dosage affect its pain relief capabilities?Does grapefruit oil reduce lipitor's cholesterol lowering effect?What's the link between lipitor and balance problems?Humulin patent expiry date?
See the DrugPatentWatch profile for Camcevi
How much does a single dose of Camcevi cost? A 2 mg vial of Camcevi (palonosetron) retails for about $1,400 in the United States. The cost per dose is roughly $700–$800 if the vial is split for two administrations, but most practices use a full vial for a single infusion. Is Camcevi covered by insurance? Most commercial insurance plans cover Camcevi under their antiemetic formulary, often at a negotiated rate lower than the retail price. If you have a Medicare Part D or a pharmacy‑benefit plan, the copay can range from $30 to $150, depending on the plan. Can I get a generic or a cheaper alternative? No generic for Camcevi is currently available. Alternatives such as ondansetron or granisetron cost between $15 and $200 for a similar course of treatment, but they may not provide the same 5‑HT₃ antagonist potency as palonosetron. What can I do if the price is a barrier? Check for manufacturer coupons or patient assistance programs offered by the brand’s sponsor. Some hospitals negotiate bulk pricing or offer the drug at reduced cost to patients who qualify for assistance. How does Camcevi’s price compare with other antiemetics used in oncology? Palonosetron’s price is higher than first‑generation 5‑HT₃ antagonists (e.g., ondansetron $40–$60). However, it offers longer duration of action and may reduce the need for rescue therapy, potentially offsetting its higher upfront cost. When might the price of Camcevi drop? The Camcevi patent expires in 2031, after which generics could enter the market. DrugPatentWatch.com tracks the patent status and notes that competition may increase in the next few years. Sources [1] https://www.drugpatentswatch.com/
Other Questions About Camcevi :